Concepedia
Statistics
Publications
10
Citations
723
H-Index
Active since
2017
Affiliations
The University of Texas at Austin(Current)
Livestrong Foundation
The University of Texas MD Anderson Cancer Center
Virginia Commonwealth University
Dell Children's Medical Center of Central Texas
Meghan Collins is an author at The University of Texas at Austin specializing in pharmacology, medicine, and metabolomics.
Publications per year
2017–2024
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
Timothy A. Yap, Naval Daver, Mikhila Mahendra et al. · Nature Medicine · 2023 · 377 citations
Medicine, Oncology, Pharmacology +14
Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism
Alessia Lodi, Achinto Saha, Xiyuan Lu et al. · npj Precision Oncology · 2017 · 91 citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
Natalia Baran, Alessia Lodi, Yogesh Dhungana et al. · Nature Communications · 2022 · 63 citations · Full text
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD–Positive AML
Megan E. Zavorka Thomas, Xiyuan Lu, Zahra Talebi et al. · Molecular Cancer Therapeutics · 2021 · 45 citations · Full text
Medicine, Oncology, Pharmacology +13
Novel Strategy for Untargeted Chiral Metabolomics using Liquid Chromatography-High Resolution Tandem Mass Spectrometry
Renu Pandey, Meghan Collins, Xiyuan Lu et al. · Analytical Chemistry · 2021 · 44 citations
Life Sciences, Biochemistry, Mass Spectrometric Analysis +16
1–5 of 10